Jaguar Health (JAGX) Current Leases (2017 - 2026)
Jaguar Health (JAGX) reported Current Leases of $261000.0 for Q1 2026, down 4.4% year-over-year from $273000.0 in Q1 2025, and up 35.94% quarter-over-quarter from $192000.0 in Q4 2025.
Jaguar Health (JAGX) Current Leases (2017 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 10 years of Current Leases data on file, last reported at $261000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $261000.0, down 4.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $261000.0 (down 4.4% YoY), and the FY2025 annual result was $192000.0, down 35.79% from the prior year.
- Current Leases improved to $261000.0 in Q1 2026 per JAGX's latest filing, from $192000.0 in the prior quarter.
- Over five years, Current Leases peaked at $526000.0 in Q3 2023 and troughed at $192000.0 in Q4 2025.
- A 5-year average of $367176.5 and a median of $368000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2025: Current Leases surged 101.25% in 2022, then tumbled 41.79% in 2025.
- A 5-year view of Current Leases shows it stood at $483000.0 in 2022, then fell by 27.95% to $348000.0 in 2023, then declined by 14.08% to $299000.0 in 2024, then plunged by 35.79% to $192000.0 in 2025, then surged by 35.94% to $261000.0 in 2026.
- Business Quant data shows JAGX's Current Leases at $261000.0 in Q1 2026, $192000.0 in Q4 2025, and $226000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 42,980.09 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 261,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 261,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Sep 30, 2025 | 226,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Mar 31, 2025 | 273,000.00 |
| Dec 31, 2024 | 299,000.00 |
| Sep 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Mar 31, 2024 | 469,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | 526,000.00 |
| Jun 30, 2023 | 515,000.00 |
| Mar 31, 2023 | 503,000.00 |
| Dec 31, 2022 | 483,000.00 |
| Sep 30, 2022 | 418,000.00 |
| Jun 30, 2022 | 390,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | 240,000.00 |
| Sep 30, 2021 | 297,000.00 |
| Jun 30, 2021 | 199,000.00 |